Owen P. Hughes Jr.
Net Worth

Last updated: 12 Jan 2021

What is Owen P. Hughes Jr. net worth?

The estimated net worth of Mr. Owen P. Hughes Jr. is at least $6,683,997 as of 12 Jan 2021. He owns shares worth $3,801,757 as insider and has received compensation worth at least $2,882,240 in Cullinan Oncology, Inc..

What is the salary of Owen P. Hughes Jr.?

Mr. Owen P. Hughes Jr. salary is $720,560 per year as Strategic Advisor in Cullinan Oncology, Inc..

How old is Owen P. Hughes Jr.?

Mr. Owen P. Hughes Jr. is 50 years old, born in 1975.

What stocks does Owen P. Hughes Jr. currently own?

As insider, Mr. Owen P. Hughes Jr. owns shares in one company:

Company	Title	Shares	Price per share	Total value
Cullinan Oncology, Inc. (CGEM)	Strategic Advisor	506,226	$7.51	$3,801,757

What does Cullinan Oncology, Inc. do?

Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with non-small cell lung cancer. Its preclinical products include CLN-049, a humanized bispecific antibody for the treatment of acute myeloid leukemia; CLN-619, a monoclonal antibody for the treatment of solid tumors; CLN-617, a fusion protein for the treatment of solid tumors; CLN-978, a T cell engaging antibody for B-cell malignancies; Opal, a bispecific fusion protein to block the PD-1 axis, and to activate the 4-IBB/CD137 pathway on T cells in tumors; and Jade, a cell therapy to target a novel senescence and cancer-related protein. The company has collaboration agreements with Cullinan Pearl Corp. to develop, manufacture, and commercialize CLN-081 and products containing CLN-081; and Adimab, LLC to discover and/or optimize antibodies. Cullinan Oncology, Inc. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.